期刊文献+

血清及胸水细胞块中CEA、CA125检测对肺腺癌的诊断价值 被引量:3

Diagnostic value of CEA and CA125 in serum and pleural effusion cell blocks in lung adenocarcinoma
下载PDF
导出
摘要 目的:比较不同方法检测不同类型标本中CEA、CA125对肺腺癌的诊断价值。方法:采用电化学发光和免疫组织化学两种不同的方法分别检测肺腺癌及良性疾病患者的外周血、胸水细胞块中CEA、CA125的表达,分析两种检测方法的诊断效能及一致性。结果:肺癌组患者血清和组织CA125、CEA水平均显著高于良性肺病组,诊断效能方面两种方法略有差别,两种方法检测CEA一致性程度中等,CA125一致性较差。结论:CEA和CA125在良恶性胸腔积液鉴别诊断方面有重要价值,血清检测具有较高的敏感性,免疫组化方法特异性更高,两种方法相互补充有助于明确诊断。 Objective:To investigate the diagnostic value of CEA and CA125 in different types of samples.Methods:Detect the expression of CEA and CA125 in serum and pleural effusion cell blocks in adenocarcinoma and benign disease patients using different method respectively,and analyze the diagnostic efficacy and consistency of the two methods.Results:The serum and tissue levels of CEA and CA125 in the lung adenocarcinoma group were significantly higher than those in the benign disease group.The two methods were different in terms of diagnostic efficacy.The consistency between the two methods for CEA is moderate,but that of CA125 is poor.Conclusion:CEA and CA125 have important value in the differential diagnosis of benign and malignant disease.Serum detection has higher sensitivity,but immunohistochemical method has higher specificity.The two methods complement each other to improve diagnostic accuracy.
作者 张舒 宋慧琴 张君娜 王大勇 ZHANG Shu;SONG Huiqin;ZHANG Junna(Department of Pathology,The First Affiliated Hospital of Henan University,Henan Kaifeng 475001)
出处 《医学检验与临床》 2022年第11期6-9,共4页 Medical Laboratory Science and Clinics
基金 开封市科技发展计划项目,项目编号:1808011,1808013。
关键词 肺腺癌 胸腔积液 CEA CA125 Lung adenocarcinoma Pleural effusion CEA CA125
  • 相关文献

参考文献7

二级参考文献50

  • 1寇仁业,孙桂武,王强修,刘桂兰,罗楠萍,邹志强,李浩,朱荣.联合检测肺癌患者血清铁蛋白和癌胚抗原的临床观察[J].癌症,1995,14(2):137-138. 被引量:8
  • 2苏学英,李甘地,唐应成.MOC-31在浆膜腔积液转移性腺癌、间皮瘤和增生间皮细胞中表达的检测价值[J].四川大学学报(医学版),2005,36(5):734-735. 被引量:3
  • 3郭桂芳,谢汝华,杨安奎,陈直华,吴秋良,刘巍巍,区深明,夏良平,陈明远,张晋昕.晚期上颌窦鳞癌组织中GST-π和PCNA的表达与预后的关系[J].癌症,2005,24(10):1267-1271. 被引量:2
  • 4Thapar M, Mishra R K, Sharma A, et al. Critical analysis of cell block versus smear examination in effusions [ J ]. J Cytol, 2009, 26 (2) : 60 -64.
  • 5Swiderek J, Morcos S, Donthireddy V, et al. Prospective study to de- termine the volume of pleural fluid required to diagnose maliguancy [J]. Chest, 2010, 137(1): 68-73.
  • 6Terry J, Leung S, Laskin J, et al. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples[ J]. Am J Surg Pathol, 2010, 34 (12) : 1805 -1811.
  • 7Kim D H, Kwon M S. Role of fine needle aspiration cytology, cell block preparation and CD63, 1:63 and CD56 immunostaining in classif- ying the specific tumor type of the lung[J]. Acta Cytol, 2010, 54 (1) : 55 -59.
  • 8Noda Y, Fujita N, Kobayashi G, et al. Diagnostic efficacy of the cell block method in comparison with smear cytology of tissue samples ob- tained by endoscopic ultrasound-guided fine-needle aspiration [ J ]. J Gastroenterol, 2010, 45 (8) : 868 - 875.
  • 9Grunnet M, Sorensen JB. Carcinoembryonic antigen(CEA) as tumor marker in lung cancer[J]. Lung Cancer,2012,76(2) :138- 143.
  • 10Matsuguma H, Suzuki H, Ishikawa y, et al. Prognostic value of preoperative serum tumor markers, including CEA, Cyfra21- 1, SCC, CA19-9, SCC, CA125, TPA, NSE, and SLX, in patientswith completely resected pathological stage I non-small cell lungcancer[J]. J Clin Oncol (Meeting Abstracts), 2007,25 (18 Suppl) :7681.

共引文献91

同被引文献42

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部